Introduction
It has been recognized for some time that lead is bound within the cell to organelles and to proteins. This binding is thought principally to occur at sulphydryl sites on the protein such as is found in its binding to haemoglobin (Barltrop and Smith, 1972) . Lead inhibits enzymes which are sulphydryl dependent such as 8-aminolaevulinic acid (ALA) dehydratase (EC 4.2.1.24) and ferrochelatase (EC 4.99.1.1.) on the haem biosynthetic pathway and lipoamide dehydrogenase which is an essential component of the pyruvate and a-ketoglutarate decarboxylase systems. The metabolic components most affected by lead would appear to be the formation of the respiratory pigments (haem and the cytochromes), energy production through inhibition of mitochondrial respiration and phosphorylation, and membrane transport through inhibition of Na+K+ATPase (Hasan et al., 1967) .
Within the cell, lead would appear to be bound principally to the particulate fractions, although the actual distribution would seem to be organ-dependent. The results on this are equivocal. In the liver, however, the distribution favours the mitochondria and this mitochondrial lead would appear to be particularly stable (Castellino and Aloj, 1969) . Little lead is found in the lysosomes (Barltrop, Barrett and Dingle, 1971) and in confirmation of this, Secchi, Alessio and Spreafico (1971) found elevated activities of mitochondrial and cytoplasmic serum enzyme markers with no change in lysosomal enzyme markers.
The changes in the activity of mitochondrial enzyme activity may be associated with leadinduced accumulation of iron within the mitochondria, as shown electronmicroscopically by Bessis and Breton Gorius (1959) ; Edwards and Elliot (1973) have shown activation of ALA synthetase by lead (EC 2.3.1.37) in vitro, this possibly being a function of depressed haem levels, followed by induction of this enzyme. This enzyme is activated by ferrous iron at low concentrations but inhibited at higher concentrations (Morrow, Urata and Goldberg, 1969) .
The association of increased mortality due to ischaemic heart disease and soft water supplies has been recognized for some time. In sixty towns in England and Wales, Stitt et al. (1973) (Moore, 1973) ; Beattie et al. (1972) (Fig. 3) . It is of note that these changes coincided with the time of maximal biochemical changes (Table 1) . After this the biochemical changes becameless marked and the fine structure returned to normal.
These elevations of lead levels followed by depression after 25 weeks in the highest dose group suggested variations in the uptake of lead from the gut due to accommodation. For these reasons the uptake of lead by rats treated at 1000 .g/l and 5000 cg/l for 30 weeks was compared with the control lead uptake, using oral 203Pb chloride. No change was observed in the total uptake of radioactive lead, although there was some variation in the time taken to reach plateau levels (Fig. 4) .
Comparison of lead uptake over one week after either oral dosage with t100 Ci 2sPb chloride or intraperitoneal injection of 50 eCi 2aPb chloride showed no change in the ratio of uptake into the various organs or into the various subcellular fractions (nuclei, mitochondria, microsomes, or cell sap) as obtained from the liver and heart (Tables 2 & 3) . (Tables 2 & 3) . 
Discussion
Lead has many effects on intermediary metabolism but haem biosynthesis is known to be particularly affected (Goldberg 1972) . Indeed the activity of the cytoplasmic enzyme 8-aminolaevulinic acid (ALA) dehydratase is taken as a bio-analytical measure of lead exposure.
These results show that there is an association of biochemical change with morphological change in the cardiac muscle of rats treated chronically with lead at 1000 ,ug/l for 25 weeks, the point at which tissue lead levels are maximal. Biochemical change is not confined to the cytoplasmic enyme ALA dehydratase but is also shown by the mitochondrial enzyme, ferrochelatase, essential for myoglobin production. There are, however, no significant changes in the activity of the other mitochondrial enzyme measured, ALA synthetase, although Edwards and Elliot (1973) (Kostial, Simonovic and Pisonic, 1971) . There was in addition no alteration in the distribution of lead in the organs.
Similar structural changes have been described by Asokan (1974) who described them as a leadinduced cardiomyopathy. His changes were induced, however, in a shorter, eight-week experiment using the much higher dose level of 1 % lead acetate. In the present experiments significant changes were observed at dose levels considerably lower than this, corresponding to the actual levels recently found in Glasgow water. The significance of these observations may be enhanced by the consideration that only 1 % of ingested lead is absorbed in the rat, whilst in man about 10% of ingested lead is absorbed. Since lead inhibits cardiac mitochondrial oxidative phosphorylation and therefore mitochondrial respiration (Cardona et al., 1971) thus producing a biochemical ischaemia, this could contribute to the clinical ischaemia produced by atheromatous occlusion of the coronary arteries. These results offer circumstantial evidence to support the view that lead may play some part in the increased mortality due to ischaemic heart disease in soft water areas.
